Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,114 | 40 | 81.2% |
| Travel and Lodging | $257.57 | 1 | 18.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $806.60 | 11 | $0 (2022) |
| ABBVIE INC. | $165.84 | 9 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $134.48 | 7 | $0 (2022) |
| BioDelivery Sciences International, Inc. | $89.58 | 5 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $77.03 | 5 | $0 (2021) |
| Baudax Bio Inc. | $50.07 | 1 | $0 (2021) |
| Nevro Corp. | $30.82 | 2 | $0 (2021) |
| Horizon Therapeutics plc | $16.81 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $20.76 | 1 | ABBVIE INC. ($20.76) |
| 2022 | $841.03 | 16 | Boston Scientific Corporation ($678.65) |
| 2021 | $509.44 | 24 | BOSTON SCIENTIFIC CORPORATION ($127.95) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/06/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2022 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $4.07 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/23/2022 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/08/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: PRIMARY CARE | ||||||
| 10/21/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: PRIMARY CARE | ||||||
| 09/06/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: PRIMARY CARE | ||||||
| 08/20/2022 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $253.59 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/19/2022 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Travel and Lodging | In-kind items and services | $257.57 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/19/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $110.83 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/09/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: PRIMARY CARE | ||||||
| 06/22/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: PRIMARY CARE | ||||||
| 03/16/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: General - Pain Management_NMD | ||||||
| 02/18/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $41.57 | General |
| Category: General - Pain Management_NMD | ||||||
| 02/15/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: PRIMARY CARE | ||||||
| 02/15/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: PRIMARY CARE | ||||||
| 12/14/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL THERAPIES (Device) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/01/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Chronic Pain | ||||||
| 11/11/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Chronic Pain | ||||||
| 11/04/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/17/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Chronic Pain | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 50 | 58 | $31,983 | $1,942 |
| 2022 | 5 | 195 | 615 | $278,549 | $37,582 |
| 2021 | 15 | 471 | 1,075 | $293,063 | $58,068 |
| 2020 | 7 | 153 | 245 | $116,426 | $14,921 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 46 | $28,838 | $1,781 | 6.2% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 12 | 12 | $3,145 | $160.40 | 5.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 420 | $236,561 | $33,924 | 14.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 62 | $18,543 | $1,843 | 9.9% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 24 | 48 | $12,581 | $1,642 | 13.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 20 | $880.77 | $148.52 | 16.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 25 | 65 | $9,983 | $24.09 | 0.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 69 | 245 | $93,642 | $20,182 | 21.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 340 | $92,135 | $19,962 | 21.7% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 16 | 16 | $18,131 | $3,971 | 21.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 35 | 35 | $11,466 | $2,509 | 21.9% |
| 95924 | Testing of autonomic (sympathetic) nervous system function, at least 5 minutes of tilt | Office | 2021 | 17 | 22 | $10,032 | $2,122 | 21.1% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2021 | 18 | 23 | $9,114 | $2,008 | 22.0% |
| 93923 | Ultrasound study of arteries of both arms and legs, complete | Office | 2021 | 18 | 23 | $9,104 | $1,953 | 21.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 42 | 67 | $4,689 | $1,247 | 26.6% |
| 96132 | Neuropsychological testing evaluation by qualified health care professional, first 60 minutes | Office | 2021 | 13 | 13 | $5,165 | $1,149 | 22.3% |
| 93922 | Ultrasound study of arteries of both arms and legs, limited | Office | 2021 | 15 | 19 | $4,877 | $1,073 | 22.0% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 16 | 16 | $2,160 | $662.08 | 30.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 39 | 58 | $2,453 | $525.30 | 21.4% |
| 96138 | Psychological or neuropsychological test administration and scoring by technician, first 30 minutes | Office | 2021 | 14 | 14 | $1,534 | $338.24 | 22.0% |
| 93040 | Tracing of electrical activity of heart using 1-3 leads with interpretation and report | Office | 2021 | 33 | 40 | $1,522 | $318.06 | 20.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 37 | 144 | $27,040 | $50.10 | 0.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 129 | $58,965 | $9,125 | 15.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 49 | $17,081 | $2,376 | 13.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $11,810 | $1,422 | 12.0% |
About Jacquelyn Rush
Jacquelyn Rush is a Family Medicine healthcare provider based in Corsicana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2019. The National Provider Identifier (NPI) number assigned to this provider is 1760023139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jacquelyn Rush has received a total of $1,371 in payments from pharmaceutical and medical device companies, with $20.76 received in 2023. These payments were reported across 41 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,114).
As a Medicare-enrolled provider, Rush has provided services to 869 Medicare beneficiaries, totaling 1,993 services with total Medicare billing of $112,513. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family
- Location Corsicana, TX
- Active Since 10/07/2019
- Last Updated 10/07/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760023139
Products in Payments
- WaveWriter Alpha Prime 16 (Device) $519.88
- General - Pain Management (Device) $158.77
- NURTEC ODT (Drug) $134.48
- GENERAL PAIN MANAGEMENT (Device) $120.77
- QULIPTA (Drug) $103.07
- BELBUCA (Drug) $89.58
- UBRELVY (Drug) $62.77
- TROKENDI XR (Drug) $62.12
- ANJESO (Drug) $50.07
- Omnia (Device) $30.82
- OXTELLAR XR (Drug) $14.91
- GENERAL THERAPIES (Device) $7.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Corsicana
Joseph Saucedo, Do, DO
Family Medicine — Payments: $3,717
William Mchenry, M.d, M.D
Family Medicine — Payments: $1,787
Dr. Shahroz Kidwai, M.d, M.D
Family Medicine — Payments: $797.77
Dale Campbell, M.d, M.D
Family Medicine — Payments: $687.75
Daniel Metzger, D.o, D.O
Family Medicine — Payments: $276.22
Justin Ward, Do, DO
Family Medicine — Payments: $103.29